CDL Blood Pressure Guide: DOT Physical & Hypertension

A high reading at a commercial-driver medical exam does not always produce the same result. The outcome depends on the systolic and diastolic numbers, whether hypertension was already treated, the response to medication, related health findings and the certified medical examiner's judgment. Understanding the federal stages helps a driver prepare without mistaking guidance for an automatic pass-or-fail chart.

Aneroid blood-pressure gauge, three reusable cuffs, stethoscope, plain medication bottle and blank clipboard on a worn mobile-clinic counter, with only the upper cab of an unbranded American Class 8 tractor visible above a concrete barrier and every truck wheel and axle hidden

The binding federal standard is in 49 CFR 391.41(b)(6): an interstate CMV driver must have no current clinical diagnosis of high blood pressure likely to interfere with safe operation. The detailed blood-pressure stages and suggested certification periods appear in Appendix A to Part 391 and FMCSA's Medical Examiner's Handbook 2024 Edition. Those stage recommendations are advisory; the medical examiner still evaluates the whole person.

This guide addresses federal interstate medical certification. A State may apply different rules to intrastate-only operation, and a motor carrier may have a safety policy that is more conservative than the federal minimum.

Start with both numbers—not just the systolic reading

Blood pressure is written as systolic over diastolic. Systolic pressure is the first number; diastolic pressure is the second. FMCSA's Stage 1 and Stage 2 descriptions use and/or, so a driver can enter the higher category because of either component. The handbook also says elevated systolic and diastolic values apply independently.

Exam readingFMCSA guidancePossible certification path
Below 140 systolic and below 90 diastolicNot in the handbook's hypertension stagesPotentially up to 24 months if the driver otherwise qualifies; the examiner may choose less
140–159 systolic and/or 90–99 diastolicStage 1May be certified for 1 year; annual examinations thereafter should be 140/90 or less
160–179 systolic and/or 100–109 diastolicStage 2One-time 3-month certificate may be used to start or adjust treatment and reach 140/90 or less
180 or higher systolic and/or 110 or higher diastolicStage 3Should not be qualified until reduced to 140/90 or less and treatment is well tolerated; then 6-month certification may be used

The first row is not a guarantee of a two-year card. A federal medical certificate can be valid for up to 24 months, but the examiner may shorten it to monitor high blood pressure or another condition. A driver also must meet the other physical-qualification standards. Review ProntoCDL's medical-card and electronic-reporting guide for the broader certification process.

How Stage 1 affects renewal

Stage 1 is 140–159 systolic and/or 90–99 diastolic. FMCSA's advisory criteria describe this range as relatively low risk for an event likely to interfere with safe CMV operation and say the driver may be medically certified for one year. The important follow-up rule is easy to miss: later certification examinations should be at or below 140/90.

If a later exam is above 140/90 but still below 160/100, the advisory criteria say a driver may receive a one-time 3-month certificate to bring the pressure to 140/90 or less. “One-time” matters. It is not a rolling three-month extension that can be repeated whenever a renewal is due.

A driver who has already used that short interval should bring the examiner accurate treatment records and avoid assuming another temporary card will be available. The medical examiner decides whether the driver meets the standard based on current findings and the full medical history.

Stage 2 uses a treatment-and-recheck window

Stage 2 is 160–179 systolic and/or 100–109 diastolic. FMCSA's criteria call this range an indication for antihypertensive drug therapy. They allow the examiner to issue a one-time 3-month certificate so treatment can be initiated or adjusted and the pressure reduced to 140/90 or less.

At the recheck, two things matter: the demonstrated blood pressure and whether treatment is well tolerated. If the reading is 140/90 or less and treatment is tolerated, the criteria say the driver may be certified for one year. A prescription alone does not establish control, and a better home reading does not replace the measurement used in the medical examination.

Use the three months as a clinical follow-up period, not a deadline to change medicine without supervision. Keep appointments, follow the treating clinician's instructions and report side effects. Drivers should never borrow medication, double a dose or stop treatment solely to influence an exam reading.

Stage 3 is not eligible for a temporary card

FMCSA's Stage 3 level begins at 180 systolic or 110 diastolic. The handbook says values apply independently, so a severe value in either component needs attention. The advisory criteria say a driver at this level should not be qualified—even for a short period—until pressure is reduced to 140/90 or less and treatment is well tolerated.

After control is demonstrated, the driver may be certified for six months and every six months thereafter if the recheck remains at or below 140/90. This schedule reflects the need for closer monitoring after severe hypertension. It does not create a federal exemption from the blood-pressure standard.

A very high reading may require prompt medical care apart from the CDL exam. The medical examiner or treating clinician should direct the appropriate response based on symptoms, repeat measurements and the individual's health. This article cannot determine whether a particular reading is an emergency.

The examiner should confirm an elevated reading

Blood pressure can change with recent activity, pain, stress, caffeine, nicotine, a full bladder, conversation, posture and cuff fit. That does not mean an elevated exam reading should be dismissed as “white coat” pressure. It means measurement technique and confirmation matter.

Appendix A advises that an elevated finding be confirmed by at least two subsequent measurements. The handbook's examination instructions also say a reading above 139/89 should be confirmed with a second measurement taken later in the examination and recorded on MCSA-5875. The certified examiner controls the exam procedure and uses readings taken during the physical-qualification examination for the certification decision.

A home log or treating-clinician record can add context, especially when it shows dates, times and consistent technique. It does not erase the examiner's measurement. If the examiner needs more information, the driver may be asked for records, additional testing or follow-up with the treating provider.

Prepare for an accurate measurement

The goal is a representative reading, not a temporary trick. Follow the clinic's instructions and tell staff about anything that could affect the result. A practical appointment routine includes:

  • take prescribed medication exactly as directed unless the treating clinician says otherwise;
  • bring a complete list of prescriptions, over-the-counter products and supplements;
  • avoid rushing into the clinic after heavy physical effort when scheduling allows;
  • ask for an appropriate cuff size and keep clothing from bunching under the cuff;
  • sit quietly in the position directed by clinic staff and avoid talking during the measurement;
  • tell the examiner about recent illness, pain, missed doses or medication changes;
  • bring useful treating-provider notes or a home log without expecting them to replace the exam reading; and
  • know the current medical-certificate expiration date before the appointment.

Do not wait until the final day of a certificate to schedule the exam. A high reading, missing record or medication side effect may require a recheck. Leaving a reasonable buffer protects time for legitimate follow-up without driving after medical certification expires.

Medication tolerance is part of the safety decision

FMCSA's advisory criteria recognize both non-drug and drug treatment. They also warn that antihypertensive medicines can cause effects such as sleepiness or fainting. Dizziness, lightheadedness, weakness or an episode of lost consciousness can be safety-critical in a commercial vehicle even when the blood-pressure number looks better.

Give the examiner an accurate medication list, including dose and recent changes. Do not hide a medicine because it might lead to more questions. The examiner needs to separate the underlying hypertension from treatment effects and other conditions. ProntoCDL's prescription-medication guide explains the distinct roles of the driver, treating clinician, medical examiner and carrier.

If symptoms arise after starting or changing treatment, contact the treating clinician and follow the carrier's reporting process. Do not operate a CMV when dizziness, faintness, severe sleepiness or another symptom could impair control. A current medical card does not override the driver's real-time duty to be fit for safe operation.

Related conditions can change the outcome

Hypertension is not evaluated in isolation. The advisory criteria note greater concern when target-organ damage is present, particularly cerebrovascular disease. The handbook also identifies end-stage renal disease and chronic organ damage as possible complications that must be evaluated under the applicable standards.

When the examiner does not know how severe the hypertension was before treatment, FMCSA recommends annual certification. Persistent hypertension despite maximal or near-maximal doses of two or three medicines may warrant evaluation for a secondary cause. Those are individualized clinical decisions, not steps a driver should diagnose alone.

Drivers with diabetes, vision changes or other medical issues should prepare the documents required for each separate pathway. The diabetes certification guide and vision-standard guide cover two common examples.

Build a renewal plan before the card expires

  1. Read the certificate. Record the exact expiration date and any limitations.
  2. Track the assigned interval. Distinguish a normal annual renewal from a one-time 3-month or continuing 6-month cycle.
  3. Schedule treatment follow-up early. Allow time for a clinician to review readings and medication tolerance.
  4. Organize records. Keep a current medication list, relevant test results and treating-provider contact information.
  5. Book a National Registry examiner. Confirm the examiner is currently listed before the appointment.
  6. Verify the new result. Check the issue date, expiration date and electronic medical-certification status after the exam.

A carrier still must monitor medical qualification as part of the driver file. The driver should provide requested documentation promptly, while the carrier should keep qualification records current under the rules explained in the driver qualification file checklist.

Practical takeaways

  • Use both systolic and diastolic numbers; either can place a reading in a higher stage.
  • Do not treat the stage table as an automatic outcome. The medical examiner evaluates overall safety and applies medical judgment.
  • Stage 1 may support a 1-year certificate, followed by an annual target of 140/90 or less.
  • Stage 2 may support one 3-month treatment window, then a 1-year certificate when control and tolerance are demonstrated.
  • Stage 3 should not receive a temporary certificate before control; after control, 6-month certification may apply.
  • Expect an elevated exam reading to be repeated and documented.
  • Bring accurate medication and treatment information, including recent changes and side effects.
  • Use home readings as context, not as a replacement for the exam measurement.
  • Schedule renewal early enough to complete legitimate follow-up before the current certificate expires.
  • Never drive through dizziness, faintness or another symptom that could make CMV operation unsafe.

CDL blood pressure FAQ

What blood pressure passes a DOT physical?

There is no single automatic pass number for every driver. FMCSA guidance uses 140/90 or less as the control target after hypertension has been identified. A reading below 140/90 may support a certificate of up to 24 months when the driver otherwise qualifies, while higher readings can lead to a 1-year, one-time 3-month or 6-month cycle depending on the stage, history, treatment tolerance and the medical examiner’s judgment.

Can a CDL driver be certified with Stage 1 hypertension?

Potentially. FMCSA’s advisory criteria define Stage 1 as 140–159 systolic and/or 90–99 diastolic and say an individual in that range may be certified for one year. Annual examinations should then show 140/90 or less; a later reading above 140/90 but below 160/100 may support a one-time 3-month certificate to reduce the pressure.

What happens with Stage 2 blood pressure at a DOT physical?

FMCSA defines Stage 2 as 160–179 systolic and/or 100–109 diastolic. The advisory criteria allow a one-time 3-month certificate to start or adjust treatment and reduce the reading to 140/90 or less. If treatment is well tolerated and the recheck is 140/90 or less, the driver may be certified for one year.

Can a driver receive a short certificate with Stage 3 hypertension?

FMCSA’s advisory criteria say a driver at the Stage 3 level should not be qualified, even briefly, until blood pressure is reduced to 140/90 or less and treatment is well tolerated. After control is demonstrated, the driver may be certified for six months and every six months thereafter while the criteria continue to be met.

Will a home blood-pressure log replace the reading at the DOT exam?

No. A home log can help the treating clinician understand patterns and can give the medical examiner useful context, but the FMCSA handbook says readings taken during the physical-qualification examination should be used for the certification decision. The examiner may request additional records or testing when needed.

Do blood-pressure medicines disqualify a commercial driver?

Not by themselves. FMCSA guidance expects the examiner to consider whether treatment controls the pressure and is well tolerated. Side effects such as sleepiness, dizziness or fainting matter because they can interfere with safe CMV operation. Drivers should provide an accurate medication list and discuss symptoms with the treating clinician and medical examiner.

Continue with the medical-card guide, medication guide and diabetes certification guide.